242 related articles for article (PubMed ID: 17996259)
1. Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
Radonjić NV; Petronijević ND; Vucković SM; Prostran MS; Nesić ZI; Todorović VR; Paunović VR
Physiol Behav; 2008 Feb; 93(3):437-43. PubMed ID: 17996259
[TBL] [Abstract][Full Text] [Related]
2. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
Radonjić NV; Knezević ID; Vilimanovich U; Kravić-Stevović T; Marina LV; Nikolić T; Todorović V; Bumbasirević V; Petronijević ND
Neuropharmacology; 2010; 58(4-5):739-45. PubMed ID: 20036264
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
Mouri A; Noda Y; Enomoto T; Nabeshima T
Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
[TBL] [Abstract][Full Text] [Related]
4. Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors.
du Bois TM; Newell KA; Han M; Deng C; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):37-40. PubMed ID: 18940225
[TBL] [Abstract][Full Text] [Related]
5. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
7. Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.
Boctor SY; Ferguson SA
Neurotoxicology; 2009 Jan; 30(1):151-4. PubMed ID: 19038286
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat.
Anastasio NC; Johnson KM
J Neurochem; 2008 Mar; 104(5):1210-8. PubMed ID: 17995927
[TBL] [Abstract][Full Text] [Related]
9. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
[TBL] [Abstract][Full Text] [Related]
10. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
11. Neonatal handling prevents the effects of phencyclidine in an animal model of negative symptoms of schizophrenia.
Tejedor-Real P; Sahagún M; Biguet NF; Mallet J
Biol Psychiatry; 2007 Apr; 61(7):865-72. PubMed ID: 17125743
[TBL] [Abstract][Full Text] [Related]
12. Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic.
Wang C; McInnis J; West JB; Bao J; Anastasio N; Guidry JA; Ye Y; Salvemini D; Johnson KM
J Pharmacol Exp Ther; 2003 Jan; 304(1):266-71. PubMed ID: 12490600
[TBL] [Abstract][Full Text] [Related]
13. Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.
Newell KA; Zavitsanou K; Huang XF
J Neurosci Res; 2007 May; 85(6):1358-63. PubMed ID: 17342780
[TBL] [Abstract][Full Text] [Related]
14. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Pedersen CS; Goetghebeur P; Dias R
J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.
Liu J; Suzuki T; Seki T; Namba T; Tanimura A; Arai H
Synapse; 2006 Jul; 60(1):56-68. PubMed ID: 16596623
[TBL] [Abstract][Full Text] [Related]
16. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
Enomoto T; Noda Y; Nabeshima T
Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
[TBL] [Abstract][Full Text] [Related]
17. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons.
Wang C; Anastasio N; Popov V; Leday A; Johnson KM
Neuroscience; 2004; 125(2):473-83. PubMed ID: 15062989
[TBL] [Abstract][Full Text] [Related]
18. Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia.
Petronijevic N; Sopta J; Doknic M; Radonjic N; Petronijevic M; Pekic S; Maric N; Jasovic-Gasic M; Popovic V
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():58-63. PubMed ID: 23811489
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
Noda Y; Nabeshima T
Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
[TBL] [Abstract][Full Text] [Related]
20. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
